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Abstract 
Objective: The role of estrogen in cognitive function and depressive symptoms is controversial 
due to discrepancies between results from randomized controlled trials (RCT) and observational 
studies. Mendelian randomization analysis may provide further insights concerning the role of 
estrogen in these outcomes as it assesses the effect of lifelong endogenous exposure but is less 
vulnerable to confounding than observational studies.  
Method: We used separate sample instrumental variable analysis to estimate the association of 
log 17β estradiol with cognitive function (Delayed 10 word recall, and Mini Mental State 
Examination (MMSE)) and depressive symptoms (Geriatric Depression Scale (GDS)) in older 
Chinese women of the Guangzhou Biobank Cohort Study (GBCS, n=3,086). The estimate was 
derived based on the Wald estimator, the ratio of the association of genetic determinants 
(rs1008805 and rs2175898) of log 17β-estradiol with cognitive function and depressive 
symptoms in GBCS and the association of log 17β-estradiol with genetic determinants in the 
sample of young women in Hong Kong (n=236). 
Results: Genetically predicted 17β-estradiol was not associated with delayed 10-word recall 
(0.42 words per log increase in 17β-estradiol (pmol/L), 95% confidence interval (CI) -0.49 to 
1.34) MMSE (0.39 per log increase in 17β-estradiol (pmol/L), 95% CI -0.87 to 1.65) or GDS 
(0.24 per log increase in 17β-estradiol (pmol/L), 95% CI -0.57 to 1.05).  
Conclusion: These results were largely consistent with evidence from RCTs and did not show 
any beneficial effect of estrogen on cognitive function and depressive symptoms. However, 
larger Mendelian randomization analyses are needed to identify any minor effects.  
Highlights 
• Mendelian randomization assesses lifelong exposure and is less prone to confounding 
• Mendelian randomization showed no effect of lifelong estrogen on cognition  
• Mendelian randomization showed no effect as well on depressive symptoms 
• Our study does not support the timing hypothesis as explanation for trial results 
• Discrepancies between observational studies and trials is likely due to confounding 
 
Introduction 
There are known sex differences in neurological function such as lower prevalence of mild 
cognitive impairment among women (1), but higher prevalence of depression (2). It has been 
speculated that estrogen, the female sex hormone, may explain these differences as estrogen may 
improve neural plasticity and the health of the neurovascular unit (3), but may also modulate 
mood via the serotonergic system (3). Observational studies consistently showed that hormone 
replacement therapy (HRT) users had a lower risk of dementia (3), but less so for depression (3), 
than non-users. The subsequent Women’s Health Initiative Memory Study (WHIMS) showed 
HRT had adverse effect on cognition (4), whilst findings from trials of estrogen or HRT for 
depression have been inconsistent (5-7). HRT users differed from non-users in terms of 
socioeconomic position and lifestyle, so unmeasured confounding may explain the discrepant 
results between these two study designs (8). However, the response to HRT could depend on the 
timing of initiation, a phenomenon known as the timing hypothesis (3, 9). Specifically, HRT 
initiated around the time of menopause may improve cognition but reduce cognition if HRT is 
initiated years after menopause. Different HRT formulations (as estrone, estradiol or estradiol 
with progesterone) may also have different effects on cognitive function (3). Replication using 
an alternative design, comparing cognition and depression in women with genetically determined 
differences in estrogen, may help elucidate the role of estrogen. A separate sample Mendelian 
randomization study, which utilizes genetic predictors of the exposure, in this case estrogen, may 
be an alternative for several reasons. First, genetic make-up is randomly allocated at conception 
analogous to the randomization process in randomized controlled trials (RCTs), giving estimates 
of association that are less susceptible to the unmeasured confounding that may bias 
observational studies (10). Mendelian randomization has increasingly been used to ascertain 
whether risk factors for poor cognitive function, such as lipids and alcohol use, are causal (11, 
12). Second, Mendelian randomization studies assess lifelong effects which is potentially more 
relevant to the timing hypothesis than randomized controlled trials where mainly 
postmenopausal women were recruited (4). On the other hand, unlike randomized controlled 
trials which assess the effect of exogenous exposures, Mendelian randomization studies assess 
the effect of endogenous exposure, and hence may be less susceptible to problems such as 
pleiotropic effect of interventions used in RCTs (13). Third, a separate sample Mendelian 
randomization study allows estimates of effects where the genetic association for the exposure 
comes from a different sample than the genetic associations for the outcome, which is a more 
efficient and less biased design (14) that enables estimation of lifelong effects of an exposure, 
such as estrogen that changes with age. Genetic determinants of  estrogen exposure in young 
women may be used to determine the effects of estrogen in older women because it is less 
susceptible to measurement error (15), and so may give more reliable estimates (14). We have 
previously used this approach to examine the role of testosterone and estrogen in cardiovascular 
disease risk factors and inflammation (16-18). In this study, we examined the relation of lifelong 
exposure to estrogen with cognition and depressive symptoms using a Mendelian randomization 
study among Southern Chinese women to clarify the role of lifelong estrogen exposure. 
 
Methods 
 
Sources of data 
Two groups of women of different ages from the same genetic background, that is, from Hong 
Kong and Guangzhou, the capital of Guangdong, in Southern China, were recruited. Most Hong 
Kong residents are first, second or third generation migrants from Guangdong (19). First, 237 
young women (mean age 21.0 years) were recruited from the University of Hong Kong, 
restricted to those with parents and at least three grandparents born in Hong Kong or Guangdong 
and not taking hormone-related medication. Morning blood samples were taken on the 4th day to 
7th day of the menstrual cycle for 17β-estradiol assessment, by immunoassay (Ortho Clinical 
Diagnostics Vitros Eci), and deoxyribonucleic acid (DNA) extraction. Self-administered 
questionnaires were used to collect information, such as socioeconomic position and health 
status.  
 
Second, we used a sample of older women (50+ years) from GBCS, an ongoing collaboration of 
Guangzhou Number 12 Hospital, the Universities of Hong Kong and Birmingham, UK (20). 
Recruitment of participants was in 3 phases. All participants were permanent residents of 
Guangzhou and members of “The Guangzhou Health and Happiness Association for the 
Respectable Elders” (GHHARE), a community social and welfare association unofficially 
aligned with the municipal government. Membership is open to older people for a monthly fee of 
4 Yuan (50US cents). About 7% of permanent Guangzhou residents aged 50+ years are members 
of GHHARE, of whom 11% (about 10,000 participants) enrolled for each of phases one, two and 
three. The inclusion criteria were that they were capable of consenting, ambulatory, and not 
receiving treatment modalities which, if omitted, may result in immediate life-threatening risk, 
such as chemotherapy or radiotherapy for cancer, or dialysis for renal failure. The methods of 
measurement have previously been reported (20). Cognitive function was assessed using the test 
of new learning ability (10-word list learning task) from a test battery developed for the 
Consortium to Establish a Registry for Alzheimer’s Disease (21). Four words “pole”, “shore”, 
“cabin”, and “engine” were replaced with “corner”, “stone”, “book”, and “stick” as in the 
adapted Consortium 10-word list learning task (22), and “butter” and “queen” were replaced by 
“soy sauce” and “chairman” as these are more culturally appropriate. During the learning phase, 
the 10-word list was read out to the participant who was then asked to recall immediately the 
words they remembered; this was repeated 3 times. After a 5-minute period of distraction, during 
which the interview was continued, the participant was then asked to recall as many of the 10 
words as he or she was able, giving the delayed recall score out of 10. In phase 3 and the 
subsequent follow up for all phases, we additionally used the Mini Mental State Examination 
(MMSE) (23). Three of the 11 tasks in the original MMSE were modified to be culturally 
appropriate and consistent with other adaptations for Chinese populations (24). Orientation in 
place was adapted according to geographical divisions of China and screening setting to: 
“country”, “province”, “city”, “hospital”, and “floor”. In the 3-word registration and recall “table” 
and “penny” were replaced by “newspaper” and “train”, while the third word remained as 
“apple”, to ensure all three words were frequently used two-character Chinese words. The 
modified MMSE has the same scale as the original MMSE (24), hence the psychometric 
properties of the measures should be similar. Depressive symptoms were assessed by the Chinese 
version of the 15-item Geriatric Depression Scale (GDS) which has been used before in Chinese 
(25). 
 
Fasting blood samples were collected at baseline recruitment in phase 3 or at follow up for 
participants recruited in other phases. Samples were stored, as whole blood or as buffy coat and 
sera, at -800C for all apart from a subset of phase 3 participants whose DNA was extracted from 
fresh blood and stored at -800C (12). The University of Hong Kong-Hospital Authority Hong 
Kong West Cluster Joint Institutional Review Board approved the study. The Guangzhou 
Medical Ethics Committee of the Chinese Medical Association approved GBCS, including the 
use of genetic data. All participants gave written, informed consent prior to participation.  
 
DNA extraction and SNP analysis 
DNA was extracted using QIAamp DNA Blood Midi Kit (Catalog No.51185) for fresh blood in 
Hong Kong, phenol-chloroform extraction for fresh blood in GBCS and magnetic bead 
extraction for previously stored specimens in GBCS (12). SNPs were selected from genes (ESR1, 
ESR2 and CYP19A1 (26-29)) functionally relevant to estradiol or breast cancer, with minor allele 
frequency >5% in Chinese (30). Five SNPs (rs2175898 from ESR1, rs1256030 and rs1256031 
from ESR2, and rs10046 and rs1008805 from CYP19A1) were analyzed at the Centre for 
Genomic Sciences of the University of Hong Kong, for the Hong Kong sample, and a 
commercial company (Beijing Capital Bio Corporation) in Beijing, for the GBCS sample, using 
a Mass ARRAY system (Sequenom, San Diego, California). For DNA quality analysis we used 
spectrophotometry for most of the samples and gel electrophoresis for four duplicate check 
controls and six randomly selected samples in each DNA sample plate. The determined sample 
concentration and A260/280 ratios were 10-20ng/uL and 1.7-2.0, respectively. A call rate <80% 
was considered failure. All SNPs passed with a call rate >95%. 
 
 
Exposure  
The exposure was genetically predicted log 17β-estradiol (pmol/L). 
 
Outcome 
The outcomes were delayed 10-word recall test score and modified MMSE score for cognitive 
function, and GDS score for depressive symptoms. The adapted Consortium 10-word list 
learning task has been validated as a culturally and educationally sensitive tool for identifying 
dementia in population-based research in developing countries (22). The modified MMSE has 
been used before (31-33). The delayed 10-word recall test, MMSE and GDS were also 
administered to all participants (phases 1-3) at follow up, so we used the test scores from follow 
up for those without baseline test scores, because MMSE and GDS was not administered at 
baseline in phases 1 and 2. 
 
Statistical analysis 
In the sample of young Chinese women from Hong Kong, we established genetic predictors of 
log 17β-estradiol based on 2 SNPs from stepwise linear regression starting with 5 SNPs with 
replication in 1,000 bootstrapping samples, as described previously (17). In the GBCS sample, 
we tested for Hardy-Weinberg equilibrium at the SNP locus on a contingency table of observed-
versus-predicted frequencies with an exact test. We used ANOVA to assess whether genetically 
predicted log 17β-estradiol was associated with potential confounders We used separate sample 
instrumental variable analysis to estimate the association of log 17β-estradiol with cognitive 
function and depressive symptoms in the sample of older Chinese women from GBCS by using 
suest (seemingly unrelated regression command in Stata) to generate the Wald estimates from 
the ratio of the association of genetic determinants of log 17β-estradiol with cognitive function 
and depressive symptoms in GBCS and the association of genetic determinants of log 17β-
estradiol with log 17β-estradiol in the sample of young women (34). Figure 1 shows the flow 
chart of the study. 
 
All statistical analyses were conducted using Stata 13.1 (StataCorp LP, College Station, Texas, 
USA). 
 
Results 
Among the young Chinese women samples (n=236, one participant was excluded because of 
invalid 17β-estradiol), the F-statistic for genetically predicted log 17β-estradiol was 13.2, with an 
adjusted R2 of 4.9%, suggesting that the analyses is unlikely to be susceptible to weak instrument 
bias. Among the 22,067 women in all 3 phases of GBCS, SNP analysis was available for 3,316 
women, with availability depending on the phase of recruitment and other logistical concerns. 
Among these 3,316 women, 3,096 (93.4%) had all selected SNPs. However, these women were 
more likely to have a higher education level and to have had non-manual jobs (Appendix 1).The 
2 SNPs used to generate the genetic score did not deviate from the Hardy Weinberg equilibrium 
(p=0.42 for rs1008805; and p=0.73 for rs2175898) in the GBCS sample. Of the 3,096 women, 
1,821 had MMSE from baseline and 1,245 from follow-up, 1,824 had GDS from baseline and 
1,261 from follow-up and 2,943 had delayed 10 word recall from baseline and 143 from follow 
up. Table 1 shows genetically predicted log 17β-estradiol, obtained from a previously derived 
genetic prediction rule ((0.1×rs1008805-0.1×rs2175898+4.7) (17), was unrelated to age, 
smoking, alcohol use, physical activity, education and longest held occupation among older 
Southern Chinese women from GBCS. 
 
Table 2 shows the instrumental variable estimates for the association of log 17β-estradiol with 
delayed 10-word recall, MMSE and GDS. Log 17β-estradiol was not associated with delayed 10 
word recall score (0.42 per unit  increase in log 17β-estradiol, 95% confidence interval (CI) -0.49 
to 1.34), MMSE scores (0.39 per unit increase in log 17β-estradiol, 95% CI -0.87 to 1.65) or 
GDS scores (0.24 per unit increase in log 17β-estradiol, 95% CI -0.57 to 1.05)  among older 
Southern Chinese women.  
 
Discussion 
This study, to our knowledge, is the first study to examine the effect of lifelong exposure to 
estrogen on cognitive function or depressive symptoms using a separate sample Mendelian 
randomization design. This study adds by showing that there is no evidence for any protective 
effect of estrogen on cognitive function, consistent with the WHIMS and other RCTs (4, 35), or 
on depressive symptoms, consistent with RCTs (5, 6). By replicating the findings from previous 
RCTs, this study also demonstrates the utility of the Mendelian randomization study design as a 
useful alternative or, ideally, precursor to RCTs. 
 
Although we used a separate sample Mendelian randomization design which is less susceptible 
to the confounding often found in observational studies, limitations exist. First, as with all study 
designs, Mendelian randomization has assumptions which are not always testable. Specifically, 
we are unable to assess if the genetic variants affected cognitive function or depressive 
symptoms only via their associations with estrogen, i.e. the exclusion restriction criteria, as we 
did not have genetic variants, estrogen, and the outcomes all measured for the same women. 
Second, we did not use estrogen related genetic variants from genome wide association studies 
(GWAS), because no such studies have reliably identified estrogen related genetic 
polymorphisms in Chinese women. Therefore, we have established our own genetic prediction 
rule in a young Chinese women sample using stepwise regressions and bootstrapping methods, 
as described previously.(17) Mendelian randomization is susceptible to confounding by 
population stratification but the participants had the same genetic origin. Fourth, our study was 
powered to detect a change of 0.23 standard deviation in the outcomes, for example an MMSE 
score of 0.8 per increase in one log unit change in estrogen (pmol/L). We could not detect 
smaller changes due to estrogen which could be important to population health but possibly are 
less clinically relevant.  Fifth, women who did not return for follow up had lower socio-
economic position than those who returned for follow up (36). Furthermore, some participants 
were chosen based on their change in cognitive function from baseline for a case control study 
examining genetic determinants of cognitive function (37). However, selection bias would only 
occur if those with a specific relation of estrogen related genetic variants with cognitive function 
or depressive symptoms did not return or were included in the case control study, which is 
unlikely.  Moreover, a sensitivity analysis excluding the women cases gave very similar 
estimates (data not shown). Lastly, our study only focused on estrogen and may not be relevant 
to the effect of combined treatment (i.e. estrogen and progestin). However, the WHIMS showed 
combined treatment did not prevent cognitive impairment (38).  The Kronos Early Estrogen 
Prevention Study (KEEPS) showed positive effect of HRT on mood although only for those 
receiving oral treatment (39), whether comparing effects by formulation for mood was part of the 
original protocol is unclear (39). 
 
The discrepancies between observational studies and RCTs could be an indicator of confounding 
by healthier attributes among users compared to non-users of HRT in observational studies (8, 
35). Notwithstanding this likely explanation, alternative explanations such as the timing 
hypothesis may explain this discrepancy (9), in particular WHIMS mainly recruited participants 
several years after their menopause (4). The null findings from our study, which examined the 
lifelong effect of estrogen, do not provide evidence in support of the timing hypothesis and is 
consistent with the WHIMS analysis restricting to participants aged 50-55 (40). Similarly, our 
null findings on estrogen and depressive symptoms are consistent with the more recent RCTs (5, 
6). Taking these studies together suggests no strong protective effect of estrogen on long term 
cognitive function or depressive symptoms in the general population.  
 
Our study adds evidence concerning the effect of estrogen on cognitive function and depressive 
symptoms using separate sample Mendelian randomization, and there is no strong evidence for 
an effect or evidence for the timing hypothesis although the issue of statistical power may 
account for the lack of evidence. However, replication in a larger Mendelian randomization 
study may examine the possibility of smaller effects of estrogen on these outcomes, with 
corresponding implications for public health and clinical practice, assuming the benefits 
outweigh any risks.  
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Table 1: Genetically Predicted Log 17β-Estradiol by Lifestyle And Socio-demographics Among 
Southern Chinese Women In The Guangzhou Biobank Cohort Study, recruited from 2003 to  
2008 and followed up till 31 December, 2012 
Characteristic  Sample size 
Predicted 
log 17β-
estradiol 
(pmol/L) 
ap value 
Age group  50-54 379 4.73 (0.10) 0.24 
 55-59 1061 4.74 (0.10)  
 60-64 696 4.73 (0.10)  
 65-69 538 4.73 (0.10)  
 70-74 289 4.73 (0.09)  
 75-79 94 4.73 (0.10)  
 80+ 38 4.74 (0.09)  
     
Smoking status Never smokers 2,992 4.7 (0.10) 0.44 
 Former smokers 52 4.8 (0.08)  
 Current smokers 45 4.7 (0.10)  
     
Alcohol status Never drinkers 2,157 4.7 (0.10) 0.70 
 Former drinkers 101 4.7 (0.10)  
 Current drinkers 808 4.7 (0.10)  
     bPhysical activity  Inactive 194 4.7 (0.10) 0.75 
(IPAQ) Minimally active 998 4.7 (0.10)  
 HEPA active 1,903 4.7 (0.10)  
     
Education Less than primary 426 4.7 (0.10) 0.26 
 Primary 1,004 4.7 (0.10)  
 Junior middle 746 4.7 (0.10)  
 Senior middle 688 4.7 (0.10)  
 Junior college 154 4.7 (0.09)  
 College 77 4.7 (0.10)  
     cLongest-held  Manual  2,099 4.7 (0.10) 0.72 
occupation Non-manual 638 4.7 (0.10)  
 Others 321 4.7 (0.10)  aP value obtained from ANOVA. 
bHEPA: Health-enhancing physical activity (i.e. vigorous activity at least 3 days a week 
achieving at least 1500 metabolic equivalent (MET) minutes per week or activity on 7 days of 
the week, achieving at least 3000 MET minutes per week (IPAQ: International Physical Activity 
Questionnaire). 
cManual occupations are agricultural worker, factory work or sales and service; non-manual are 
administrator/ manager, professional/technical, military/disciplined. 
Table 2: Effect of Genetically Predicted Log 17β-estradiol On Delayed 10-word Recall, Mini 
Mental State Examination and Geriatric Depression Scale Scores Among Southern Chinese 
Women In The Guangzhou Biobank Cohort Study (Recruited from 2003 to 2008 and followed 
up till 31 December, 2012) Using a Mendelian Randomization Design 
Measure Sample size Estimate 95% Confidence Interval 
Delayed 10 word recall test (per word) 3,086 0.42 -0.49 to 1.34 
    
Mini Mental State Examination (per item) 3,066 0.39 -0.87 to 1.65 
    
Geriatric Depression Scale (per item) 3,085 0.24 -0.57 to 1.05 
 
 
  
 Figure 1: Flow chart of the study. A separate-sample instrumental variable analysis with genetic 
instruments, i.e. Mendelian randomization analysis, was used. See detailed in the Methods 
  
Appendix 1: Characteristics of participants with or without data among older Chinese women in the 
Guangzhou Biobank Cohort Study   
Characteristics  Participants with data 
Participants 
with missing 
data 
 
ap value 
Sample size  3,095 18,946  
Education (%) Less than primary 13.8 12.8 <0.001 
 Primary 32.4 35.4  
 Junior middle 24.1 25.5  
 Senior middle 22.2 20.8  
 Junior college 5.0 4.0  
 College 2.5 1.6  
     
Sample size  3,058 18,873  
bLongest-held  Manual  68.6 67.5 <0.001 
Occupation (%) Non-manual 20.9 18.1  
 Others 10.5 14.4  aP value obtained from chi-square test. 
bManual occupations are agricultural worker, factory work or sales and service; non-manual are 
administrator/ manager, professional/technical, military/disciplined. 
 
 
 
